Revenue | ₹724.98Cr |
Net Profits | ₹90.55Cr |
Net Profit Margins | 12.49% |
Marksans Pharma Ltd’s revenue jumped 25.75% since last year same period to ₹724.98Cr in the Q4 2024-2025. On a quarterly growth basis, Marksans Pharma Ltd has generated 2.15% jump in its revenue since last 3-months.
Marksans Pharma Ltd’s net profit jumped 15.66% since last year same period to ₹90.55Cr in the Q4 2024-2025. On a quarterly growth basis, Marksans Pharma Ltd has generated -13.4% fall in its net profits since last 3-months.
Marksans Pharma Ltd’s net profit margin fell -8.02% since last year same period to 12.49% in the Q4 2024-2025. On a quarterly growth basis, Marksans Pharma Ltd has generated -15.22% fall in its net profit margins since last 3-months.
The revenue for Marksans Pharma Ltd in the Q4 results 2024 was ₹724.98Cr.
The net profit for Marksans Pharma Ltd in the Q4 results 2024 was ₹90.55Cr.
The net profit margin for Marksans Pharma Ltd in the Q4 results 2024 was 12.49%.
The revenue for Marksans Pharma Ltd in the Q4 results 2023 was ₹576.54Cr.
The net profit for Marksans Pharma Ltd in the Q4 results 2023 was ₹78.29Cr.
The net profit margin for Marksans Pharma Ltd in the Q4 results 2023 was 13.58%.